- Home
- CRDF vs RMTI Comparison
CRDF vs RMTI Comparison
Compare CRDF & RMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRDF
- RMTI
- Stock Information
- Founded
- CRDF 1999
- RMTI 1994
- Country
- CRDF United States
- RMTI United States
- Employees
- CRDF N/A
- RMTI N/A
- Industry
- CRDF Biotechnology: Biological Products (No Diagnostic Substances)
- RMTI Biotechnology: Pharmaceutical Preparations
- Sector
- CRDF Health Care
- RMTI Health Care
- Exchange
- CRDF Nasdaq
- RMTI Nasdaq
- Market Cap
- CRDF 143.4M
- RMTI 127.2M
- IPO Year
- CRDF N/A
- RMTI 1998
- Fundamental
- Price
- CRDF $2.58
- RMTI $2.36
- Analyst Decision
- CRDF Strong Buy
- RMTI Strong Buy
- Analyst Count
- CRDF 3
- RMTI 2
- Target Price
- CRDF $9.33
- RMTI $7.00
- AVG Volume (30 Days)
- CRDF 1.1M
- RMTI 1.1M
- Earning Date
- CRDF 11-07-2024
- RMTI 11-12-2024
- Dividend Yield
- CRDF N/A
- RMTI N/A
- EPS Growth
- CRDF N/A
- RMTI N/A
- EPS
- CRDF N/A
- RMTI N/A
- Revenue
- CRDF $688,000.00
- RMTI $98,917,000.00
- Revenue This Year
- CRDF $15.00
- RMTI $22.20
- Revenue Next Year
- CRDF N/A
- RMTI $8.76
- P/E Ratio
- CRDF N/A
- RMTI N/A
- Revenue Growth
- CRDF 49.57
- RMTI 22.37
- 52 Week Low
- CRDF $1.07
- RMTI $1.16
- 52 Week High
- CRDF $6.42
- RMTI $5.15
- Technical
- Relative Strength Index (RSI)
- CRDF 41.24
- RMTI 30.47
- Support Level
- CRDF $2.85
- RMTI $3.50
- Resistance Level
- CRDF $4.38
- RMTI $5.15
- Average True Range (ATR)
- CRDF 0.45
- RMTI 0.35
- MACD
- CRDF -0.10
- RMTI -0.19
- Stochastic Oscillator
- CRDF 2.70
- RMTI 2.95
About CRDF Cardiff Oncology Inc.
Cardiff Oncology Inc a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical program in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC").
About RMTI Rockwell Medical Inc.
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, and acid and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate among others.